Loading…
Terumo Medical Corporation broke ground on a new 64,000-square-foot manufacturing facility at its Caguas, Puerto Rico site, representing a $30 million investment. The expansion will increase production capacity for the Angio-Seal Vascular Closure Device and is scheduled for completion by summer 2025.
“This expansion is another investment by Terumo as global demand for the company’s Angio-Seal Vascular Closure Device continues to increase.”terumo.com
Summarized from public sources; check the original articles before acting on it.